SP
Syndax Pharmaceuticals Inc
🇩🇪XFRA.1T3GermanyHealthcare
€15.74EURup +0.25 (+1.61%)OpenEnd of day6:53 PM
Price€15.74+0.25 (+1.61%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US87164F1057
- CUSIP
- Not reported
Company
- Employees
- 298
- Headquarters
- New York, United States
- Website
- https://syndax.com
- CEO
- Mr. Michael A. Metzger M.B.A.
Market
- Shares outstanding
- 86.9M
- Market cap
- €1.37B
Highlights
No high and low reported for today's session.
- Market cap
- €1.37B
- EPS LTM
- -$2.54calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $252M+222.34%up year on year
- Net income
- -$220.77M+34.1%up year on year
- Gross margin
- 97.47%+1.35%up year on year
- Free cash flow
- -$220.87M+27.03%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.